About Sapient Capital
Sapient Capital is a venture capital firm founded in 2000. It is primarily based out of Los Angeles, United States. As of Mar 2010, Sapient Capital has invested in 4 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across Life Sciences and High Tech sectors. Most recently it participated in the $***** Series A round of Hemosphere Overall, Sapient Capital portfolio has seen 3 acquisitions, namely Hansen Medical, Hemosphere and Arbor Surgical Technologies. A lot of funds co-invest with Sapient Capital, with names like Kaiser Permanente Ventures sharing a substantial percentage of its portfolio. Sapient Capital has team of 46 people including 9 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A & Series C
Portfolio Acquisitions
Sapient Capital's List of All Investments
Sapient Capital has a portfolio of 4 companies. Their most notable investments include Hansen Medical and ValenTx.Their portfolio spans across and United States. They have invested in Life Sciences, High Tech, across Series A, Series C stages. Here is the list of all investments by Sapient Capital:Hansen Medical designs advanced medical robotics for positioning, manipulation and control of catheters and catheter-based technologies. Their Magellan Robotic System is an intelligent catheter for use in cardiac arrhythmia. Their first product was Sensei Robotic Catheter System. Also manufacture Artisian Extend Catherter. Acquired AorTxn (offers device solution for percutaneous replacement) in Nov, 2007.
Key facts about Hansen Medical
- Founded Year: 2002
- Location: Mountain View (United States)
- Stage: Acquired
- Total Funding till date: $68M
- Employee Count: 7 as on Aug 31, 2026
- Investors: Catalyst Health Ventures, Vanguard Ventures and 6 Others
- Latest Funding Round: Post IPO, Mar 25, 2015, $*****
- Highlight: Acquired
2. ValenTx
ValenTx is a development-stage medical device company focused on minimally invasive, non-surgical approaches for the treatment of morbid obesity and related disorders such as hypertension and type-2 diabetes. The technology uses a non-surgical, adjustable, removable, and replaceable endoluminal bypass sleeve device(the ValenTx Bypass Sleeve) to treat obesity. The company claims that its device mimics the therapeutic mechanisms of a Roux-en-Y gastric bypass but obtains these with an implantable device, that does not require surgery, gastric stapling or a permanent changes to the patient's anatomy. As of 2016, the product is yet to receive FDA approval.
Key facts about ValenTx
- Founded Year: 2002
- Location: Carpinteria (United States)
- Stage: Deadpooled
- Total Funding till date: $48.7M
- Employee Count: 9 as on Apr 30, 2026
- Investors: Medtronic, Kaiser Permanente Ventures and 6 Others
- Latest Funding Round: Series B, Feb 19, 2019, $*****
3. Hemosphere
Hemodialysis access solutions improving patient outcomes and reducing catheter dependency. They specialize in innovative medical devices designed to improve hemodialysis access for patients with failing fistulas or grafts. Their flagship product offers a fully subcutaneous solution clinically proven to maintain long-term access, reduce infections, and improve dialysis adequacy. They provide comprehensive resources, including product finders, support videos, brochures, and educational materials for healthcare professionals. They are committed to advancing patient care through innovative medical technology and comprehensive support. Their solutions address critical needs in hemodialysis, offering alternatives to traditional catheters and improving the quality of life for patients.
Key facts about Hemosphere
- Founded Year: 1998
- Location: Kennesaw (United States)
- Stage: Acquired
- Total Funding till date: $9.3M
- Employee Count: 5 as on Aug 31, 2026
- Investors: Kaiser Permanente Ventures, Ascension Ventures and 5 Others
- Latest Funding Round: Series A, Mar 31, 2010, $*****
- Highlight: Acquired
Arbor Surgical Technologies is a cardiovascular device company focused on the minimally invasive heart valve replacement. It develops the modular Trilogy Aortic Valve System and sutureless TRE implantation technologies. Signed an exclusive licensing deal with Medtronic for manufacturing, marketing and distribution rights to Arbor's advanced trilobal pericardial valve technologies The company was later acquired by Medtronic.
Key facts about Arbor Surgical Technologies
- Founded Year: 2002
- Location: Irvine (United States)
- Stage: Acquired
- Total Funding till date: $20M
- Employee Count: 4 as on Jun 30, 2026
- Investors: Kaiser Permanente Ventures, Baird Capital and 7 Others
- Latest Funding Round: Series C, Jan 30, 2008, $*****
- Highlight: Acquired
Sapient Capital's Investments by Stage
Sapient Capital has made 2 investments in Series A stage with an average round size of $8.15M and 2 investments in Series C stage with an average round size of $25M.Stage of entry | No. of Investments |
|---|---|
Series A | 2 |
Series C | 2 |
Note: We have considered here, only first round of investments
Sapient Capital's Investments by Sector
Sapient Capital has a diverse portfolio, with companies operating in the Life Sciences, High Tech and Robotics - Industry Applications. Notably, it has invested in 4 Enterprise (B2B) companies, 4 Tech companies, 3 Software companies and 3 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 4 |
High Tech | 1 |
Robotics - Industry Applications | 1 |
Note: We have considered here, only first round of investments
Sapient Capital's Investments by Geography
Sapient Capital has made most investments in United States (4).Sapient Capital's recent investments
Sapient Capital has not made any investment in 2026 so far.Here are the most recent investments by Sapient Capital:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Mar 31, 2010 | United States | Series A | 8104 | ||
Sep 08, 2009 | United States | Series B | 8074 | [+5] | |
Jan 30, 2008 | United States | Series C | 1980 | ||
May 2006 | United States | Series A | 8987 | [+3] | |
Nov 17, 2005 | United States | Series C | 1455 |
Acquired companies in Sapient Capital's Portfolio
3 companies from Sapient Capital's portfolio have been acquired. The most recent acquisition was Hansen Medical in Apr 2016 by Auris Health for $*****.Here are Sapient Capital's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Apr 20, 2016 | Nov 17, 2005 | Series C | 6975 | |
Feb 04, 2016 | Mar 31, 2010 | Series A | 5731 | |
Jan 28, 2008 | Jan 30, 2008 | Series C | 4017 |
Team profile of Sapient Capital
Sapient Capital has a team of 46 members including 9 Partners located in United States. Sapient Capital's team does not sit on the board of any company as of now.Here is a list of top team members in Sapient Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Carmel | - | ||
Partner | United States | - | ||
Partner | Indianapolis | - | - | |
Partner | Indianapolis | - | ||
Partner | - | - | ||
Partner | Indianapolis | - | ||
Partner | Indianapolis | - | ||
Partner | Indianapolis | - | ||
Partner | Indianapolis | - |
Co-investors of Sapient Capital
Over the past 21 years, 21 investors have co-invested in Sapient Capital's portfolio companies. This includes only funds.
- Top Co-investors of Sapient Capital: 19 investors entered a company along with Sapient Capital. These include investors like Kaiser Permanente Ventures (3 companies).
- Invested after Sapient Capital: Medtronic (1 company) and SV Health Investors (1 company) are the investors which have invested in Sapient Capital's portfolio after their investments.
Recent News related to Sapient Capital
•
KKR & Co. Inc. $KKR Shares Sold by Sapient Capital LLCdailypolitical.com•Aug 03, 2026•KKR, Sapient Capital
•
Eli Lilly and Company $LLY Shares Acquired by Sapient Capital LLCMarketBeat•May 18, 2026•Lilly, Sapient Capital, Engage Bio
•
Sapient Capital LLC Makes New Investment in Uranium Energy Corp. $UECMarketBeat•Dec 28, 2025•Sapient Capital, Uranium Energy
•
KMG Fiduciary Partners LLC Raises Holdings in Amazon.com, Inc. $AMZNMarketBeat•Dec 25, 2025•KMG Fiduciary Partners, Amazon, MeadowbrookWealth, Mad River Investors and 13 others
•
Sendero Wealth Management LLC Raises Stock Position in Booking Holdings Inc. $BKNGMarketBeat•Dec 18, 2025•Booking, Sendero, Sapient Capital, Fort Washington Investment Advisors and 1 other
•
Sapient Capital Recruits Joshua Mandelbaum as Partner and Wealth AdvisorPR Newswire•Nov 19, 2025•Sapient Capital
•
9,083 Shares in Centene Corporation $CNC Acquired by Sapient Capital LLCMarketBeat•Sep 18, 2025•Centene, Sapient Capital
•
12,758 Shares in Barrick Mining Corporation $B Acquired by Sapient Capital LLCMarketBeat•Sep 18, 2025•Barrick, Sapient Capital, Xcel Wealth
•
JPMorgan Chase & Co. (NYSE:JPM) Shares Acquired by Sapient Capital LLCMarketBeat•Feb 20, 2025•JPMorgan Chase, Sapient Capital
•
Sapient Capital LLC Invests $256,000 in Exelixis, Inc. (NASDAQ:EXEL)MarketBeat•Feb 13, 2025•Exelixis, Sapient Capital
